site banner

Small-Scale Question Sunday for December 24, 2023

Do you have a dumb question that you're kind of embarrassed to ask in the main thread? Is there something you're just not sure about?

This is your opportunity to ask questions. No question too simple or too silly.

Culture war topics are accepted, and proposals for a better intro post are appreciated.

4
Jump in the discussion.

No email address required.

I would wager it's largely the stigma around amphetamines in general. I don't know any good reason why you'd ban those and allow phenidates, though I know Japan takes the opposite route and bans both, RIP ADHD-ists.

I don't think it's so much a fear of allowing legal amphetamines as much as an aversion to the entire class in general. And there's not much impetus to change things, at least in India, awareness of ADHD is minimal, and "a" drug exists, so it's not like it goes entirely untreated. MPH is ok, in effectiveness if not in terms of how pleasant it is to use.

(In terms of pure availability, India manufactures a ton of the stuff, including what you might import in the States, so it's little surprise we don't have a shortage)

So the status quo allows ADHD to be treated without introducing the wildcard of amphetamines. This makes sense. From what my Indian friends and acquaintances tell me, mental/psychiatric health awareness in general is minimal there so I'm not surprised there is no urgency to make changes to a system that provides at least some avenue for treatment.

I know multiple people that purchase all of their pharmaceuticals, from OTCs to scheduled drugs like modafinil, from online Indian pharmacies (mostly as a work-around for various insane US pharma and insurance pricing) so that also makes sense. Thanks.